Selen Al
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Selen Al has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aykut Kul
Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University, 34116 Istanbul, Turkiye
4 shared publications - Olcay Sagirli
Istanbul University
4 shared publications - Ali Osman Sarikaya
Istanbul University
1 shared publication - Armağan Önal
Istanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, 34116 Beyazit, Istanbul, Turkey
1 shared publication - Gülsüm Altıparmak Ülbegi
Istanbul Universitesi
1 shared publication - Merve Nesetoglu
Istanbul University
1 shared publication
Latest Publications
- 26 December 2025
- Published by ACG Publications in Journal of Chemical Metrology
- Vol. 19 (2) , 199-208
Simultaneous determination of pinaverium bromide, medazepam, and their related impurities in combined dosage form by UPLC–QDA
A rapid ultra-performance liquid chromatographic method coupled with a quadrupole detector (UPLC–QDA) was developed and validated for the simultaneous determination of pinaverium bromide, medazepam, and their related substances in a newly developed fixed-dose pharmaceutical formulation. Chromatographic separation was achieved on an Acquity BEH C18 column (100 × 2.1 mm, 1.7 µm) using a gradient elution of 25 mM ammonium formate buffer (pH 3.5) and acetonitrile at a flow rate of 0.6 mL/min and a column temperature of 45 °C. The total run time was 11 min, providing complete resolution of all analytes without interference. Linearity was demonstrated (R² ≥ 0.999) within the ranges of 2–400 ng/mL for medazepam, 10–2000 ng/mL for pinaverium bromide, 5–1000 ng/mL for RS1 (medazepam impurity), and 10–2000 ng/mL for RS3–RS6 (pinaverium bromide impurities). The limits of detection (LOD) and quantitation (LOQ) were 0.17 and 0.50 ng/mL for medazepam and 0.43 and 1.30 ng/mL for pinaverium bromide, respectively, while LOD and LOQ values for related substances ranged between 0.22–0.91 ng/mL and 0.66–2.70 ng/mL. The method was validated in accordance with the ICH Q2(R2) guideline. The validated method was successfully applied for the simultaneous quantification of pinaverium bromide, medazepam, and their respective impurities (RS1–RS6) in commercial film-coated tablets (50 mg/10 mg), demonstrating its applicability for routine quality control and stability testing of fixed-dose combination formulations.
- 26 December 2025
- Published by ACG Publications in Journal of Chemical Metrology
- Vol. 19 (2) , 199-208
Simultaneous determination of pinaverium bromide, medazepam, and their related impurities in combined dosage form by UPLC–QDA
A rapid ultra-performance liquid chromatographic method coupled with a quadrupole detector (UPLC–QDA) was developed and validated for the simultaneous determination of pinaverium bromide, medazepam, and their related substances in a newly developed fixed-dose pharmaceutical formulation. Chromatographic separation was achieved on an Acquity BEH C18 column (100 × 2.1 mm, 1.7 µm) using a gradient elution of 25 mM ammonium formate buffer (pH 3.5) and acetonitrile at a flow rate of 0.6 mL/min and a column temperature of 45 °C. The total run time was 11 min, providing complete resolution of all analytes without interference. Linearity was demonstrated (R² ≥ 0.999) within the ranges of 2–400 ng/mL for medazepam, 10–2000 ng/mL for pinaverium bromide, 5–1000 ng/mL for RS1 (medazepam impurity), and 10–2000 ng/mL for RS3–RS6 (pinaverium bromide impurities). The limits of detection (LOD) and quantitation (LOQ) were 0.17 and 0.50 ng/mL for medazepam and 0.43 and 1.30 ng/mL for pinaverium bromide, respectively, while LOD and LOQ values for related substances ranged between 0.22–0.91 ng/mL and 0.66–2.70 ng/mL. The method was validated in accordance with the ICH Q2(R2) guideline. The validated method was successfully applied for the simultaneous quantification of pinaverium bromide, medazepam, and their respective impurities (RS1–RS6) in commercial film-coated tablets (50 mg/10 mg), demonstrating its applicability for routine quality control and stability testing of fixed-dose combination formulations.
- 22 November 2025
- Published by ACG Publications in Journal of Chemical Metrology
- Vol. 19 (1) , 1-8
Determination of sulfur in topical formulations by GC-MS
A simple, sensitive, and validated gas chromatography–mass spectrometry (GC–MS) method was developed for the quantitative determination of sulfur in topical formulations. The separation was achieved on a TR-5MS capillary column (30 m × 0.25 mm ID, 0.25 µm film thickness) using helium as the carrier gas at a flow rate of 1 mL/min. The oven temperature was maintained at 190 °C, and the total analysis time was 13 min. Detection was performed in selective ion monitoring (SIM) mode at m/z 64. The injection volume was 1 µL. The method exhibited excellent linearity within the concentration range of 0.75–15.00 µg/mL. The lower limit of detection (LOD) and quantification (LOQ) were found to be 0.25 µg/mL and 0.75 µg/mL, respectively. Mean recovery values ranged from 98% to 102%, with intra- and inter-day precisions (RSD) not exceeding 2%. Method validation was conducted in accordance with the ICH Q2(R1) guidelines. Furthermore, measurement uncertainty was evaluated following the EURACHEM approach. The validated method was successfully applied to the determination of sulfur in commercial topical formulations, demonstrating its suitability for routine quality control analysis.
- 22 November 2025
- Published by ACG Publications in Journal of Chemical Metrology
- Vol. 19 (1) , 1-8
Determination of sulfur in topical formulations by GC-MS
A simple, sensitive, and validated gas chromatography–mass spectrometry (GC–MS) method was developed for the quantitative determination of sulfur in topical formulations. The separation was achieved on a TR-5MS capillary column (30 m × 0.25 mm ID, 0.25 µm film thickness) using helium as the carrier gas at a flow rate of 1 mL/min. The oven temperature was maintained at 190 °C, and the total analysis time was 13 min. Detection was performed in selective ion monitoring (SIM) mode at m/z 64. The injection volume was 1 µL. The method exhibited excellent linearity within the concentration range of 0.75–15.00 µg/mL. The lower limit of detection (LOD) and quantification (LOQ) were found to be 0.25 µg/mL and 0.75 µg/mL, respectively. Mean recovery values ranged from 98% to 102%, with intra- and inter-day precisions (RSD) not exceeding 2%. Method validation was conducted in accordance with the ICH Q2(R1) guidelines. Furthermore, measurement uncertainty was evaluated following the EURACHEM approach. The validated method was successfully applied to the determination of sulfur in commercial topical formulations, demonstrating its suitability for routine quality control analysis.
- Open Access
- 13 July 2025
- Published by EUCHEMBIOJ Publishing Platform in The European Chemistry and Biotechnology Journal
- Vol. 2026 (5) , e2026-002
GC-MS analysis of volatile compounds from pine tar using DLLME and cytotoxicity assessment
Pine tar has long been valued for its dermatological and antimicrobial properties; however, its volatile and semi-volatile component profile remains underexplored from a sustainable bioprospecting perspective. In this study, we combined dispersive liquid–liquid microextraction (DLLME) with GC-MS to develop a rapid, green workflow for profiling pine-tar volatiles, achieving greater than or equal to 50-fold enrichment from a 100 mg sample in under 10 min. GC-MS analysis on a TRB-5MS column (90 min gradient) resolved 45 compounds (match ≥ 77 %), with sesquiterpenes accounting for 71.3 % of the total area (isolongifolene 30.3 %; isobornyl acetate 16.0 %; borneol 12.4 %; (+)-longicyclene 12.5 %). Monoterpene alcohols comprised 4.4 %, while minor oxidized derivatives contributed < 3 %. Compared to conventional hydrodistillation, DLLME reduced chlorinated solvent usage by 90 % and enhanced recovery of high-boiling terpenoids by ~ 25 %. Furthermore, the cytotoxic effect of pine tar was investigated on human umbilical vein/vascular endothelium cells (HUVEC) using 3-[4,5-dimethylthiazol-2-yl]-5[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium (MTS) cell viability assay, revealing a low level of toxicity. The resulting chemical fingerprint high lights the biotechnological potential of sesquiterpene scaffolds such as isolongifolene for microbial production and biocatalytic transformations. It also supports enzyme-based functionalization strategies for isobornyl acetate and borneol, and opens avenues in sustainable perfumery, pharmaceutical intermediates, and biofuel applications. This semi-quantitative and eco-friendly platform offers a practical foundation for the biotechnological valorization and green production of pine-tar terpenoids. In addition, the observed low cytotoxicity of pine tar contributes to the preliminary safety assessment of this natural product on human endothelial cells.
- 13 July 2025
- Published by EUCHEMBIOJ Publishing Platform in The European Chemistry and Biotechnology Journal
- Vol. 2026 (5) , e2026-002
Open AccessGC-MS analysis of volatile compounds from pine tar using DLLME and cytotoxicity assessment
Pine tar has long been valued for its dermatological and antimicrobial properties; however, its volatile and semi-volatile component profile remains underexplored from a sustainable bioprospecting perspective. In this study, we combined dispersive liquid–liquid microextraction (DLLME) with GC-MS to develop a rapid, green workflow for profiling pine-tar volatiles, achieving greater than or equal to 50-fold enrichment from a 100 mg sample in under 10 min. GC-MS analysis on a TRB-5MS column (90 min gradient) resolved 45 compounds (match ≥ 77 %), with sesquiterpenes accounting for 71.3 % of the total area (isolongifolene 30.3 %; isobornyl acetate 16.0 %; borneol 12.4 %; (+)-longicyclene 12.5 %). Monoterpene alcohols comprised 4.4 %, while minor oxidized derivatives contributed < 3 %. Compared to conventional hydrodistillation, DLLME reduced chlorinated solvent usage by 90 % and enhanced recovery of high-boiling terpenoids by ~ 25 %. Furthermore, the cytotoxic effect of pine tar was investigated on human umbilical vein/vascular endothelium cells (HUVEC) using 3-[4,5-dimethylthiazol-2-yl]-5[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium (MTS) cell viability assay, revealing a low level of toxicity. The resulting chemical fingerprint high lights the biotechnological potential of sesquiterpene scaffolds such as isolongifolene for microbial production and biocatalytic transformations. It also supports enzyme-based functionalization strategies for isobornyl acetate and borneol, and opens avenues in sustainable perfumery, pharmaceutical intermediates, and biofuel applications. This semi-quantitative and eco-friendly platform offers a practical foundation for the biotechnological valorization and green production of pine-tar terpenoids. In addition, the observed low cytotoxicity of pine tar contributes to the preliminary safety assessment of this natural product on human endothelial cells.
- Open Access
- 25 January 2025
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- Vol. 1 (1) , e25005-80
Application of salt-assisted liquid-liquid extraction in bioanalytical methods
This review provides a comprehensive analysis of bioanalytical methods employed for the quantification of drug molecules in various biological matrices, including human plasma, urine, breast milk, and mouse plasma. The study not only examines traditional sample preparation techniques such as protein precipitation (PP), liquid-liquid extraction (LLE), and solid-phase extraction (SPE), but also delves into the relatively new and innovative salting-assisted liquid-liquid extraction (SALLE). It offers a thorough comparison of analytical methods utilizing SALLE, focusing on key parameters such as analysis time, calibration range, and the type and quantity of salts and organic solvents used. This review aims to serve as an essential resource for researchers and practitioners in selecting the most suitable bioanalytical methods for pharmacokinetic studies and drug monitoring, ultimately enhancing data quality and analytical efficiency in both clinical and research settings.
- 25 January 2025
- Published by EUCHEMBIOJ Publishing Platform in Euchembioj Reviews
- Vol. 1 (1) , e25005-80
Open AccessApplication of salt-assisted liquid-liquid extraction in bioanalytical methods
This review provides a comprehensive analysis of bioanalytical methods employed for the quantification of drug molecules in various biological matrices, including human plasma, urine, breast milk, and mouse plasma. The study not only examines traditional sample preparation techniques such as protein precipitation (PP), liquid-liquid extraction (LLE), and solid-phase extraction (SPE), but also delves into the relatively new and innovative salting-assisted liquid-liquid extraction (SALLE). It offers a thorough comparison of analytical methods utilizing SALLE, focusing on key parameters such as analysis time, calibration range, and the type and quantity of salts and organic solvents used. This review aims to serve as an essential resource for researchers and practitioners in selecting the most suitable bioanalytical methods for pharmacokinetic studies and drug monitoring, ultimately enhancing data quality and analytical efficiency in both clinical and research settings.
- Open Access
- 2 January 2024
- Published by EUCHEMBIOJ Publishing Platform in The European Chemistry and Biotechnology Journal
- No. 1,p. 39-46
Salt-assisted liquid–liquid microextraction for determination of haloperidol in human plasma by LC-MS/MS
Haloperidol is an antipsychotic used in the treatment of schizophrenia. Compared to other antipsychotics, it is widely used in developing countries due to its affordable price. Haloperidol has a narrow therapeutic range and variable pharmacokinetics; therefore, therapeutic drug monitoring (TDM) is recommended. For this reason, in this study, an easily applicable, fast, selective, accurate, reliable, and economical LC-MS/MS method was developed for the determination of haloperidol in human plasma for use in TDM and also method was validated according to European Medicines Agency (EMA) Bioanalytical method validation guidelines. In the developed method, analyte and internal standard were extracted from plasma by salt-assisted liquid-liquid microextraction (SALLME) technique and after that injected to the LC system. The limit of quantification of haloperidol was determined as 1 ng/ml. The calibration curve was validated between 1-15 ng/ml, with correlation coefficients >0.99. In addition, the developed method was used to determine drug concentration levels in the plasma of real patients.
- 2 January 2024
- Published by EUCHEMBIOJ Publishing Platform in The European Chemistry and Biotechnology Journal
- No. 1,p. 39-46
Open AccessSalt-assisted liquid–liquid microextraction for determination of haloperidol in human plasma by LC-MS/MS
Haloperidol is an antipsychotic used in the treatment of schizophrenia. Compared to other antipsychotics, it is widely used in developing countries due to its affordable price. Haloperidol has a narrow therapeutic range and variable pharmacokinetics; therefore, therapeutic drug monitoring (TDM) is recommended. For this reason, in this study, an easily applicable, fast, selective, accurate, reliable, and economical LC-MS/MS method was developed for the determination of haloperidol in human plasma for use in TDM and also method was validated according to European Medicines Agency (EMA) Bioanalytical method validation guidelines. In the developed method, analyte and internal standard were extracted from plasma by salt-assisted liquid-liquid microextraction (SALLME) technique and after that injected to the LC system. The limit of quantification of haloperidol was determined as 1 ng/ml. The calibration curve was validated between 1-15 ng/ml, with correlation coefficients >0.99. In addition, the developed method was used to determine drug concentration levels in the plasma of real patients.